Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Published in: Gastric Cancer 3/2003

01-09-2003 | Case report

Simultaneous early adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach associated with Helicobacter pylori infection

Authors: Takehiro Sakai, Yuta Ogura, Junichi Narita, Takemichi Suto, Daisuke Kimura, Susumu Ainai, Hajime Fujita, Mitsuru Kamada

Published in: Gastric Cancer | Issue 3/2003

Login to get access
Metadata
Title
Simultaneous early adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach associated with Helicobacter pylori infection
Authors
Takehiro Sakai
Yuta Ogura
Junichi Narita
Takemichi Suto
Daisuke Kimura
Susumu Ainai
Hajime Fujita
Mitsuru Kamada
Publication date
01-09-2003
Publisher
Springer-Verlag
Published in
Gastric Cancer / Issue 3/2003
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-003-0241-8

Other articles of this Issue 3/2003

Gastric Cancer 3/2003 Go to the issue

Original article

Detection of Epstein-Barr virus in gastric carcinoma cells and surrounding lymphocytes

Original article

Intestinal phenotypic expression of gastric depressed adenomas and the surrounding mucosa

Original article

Biweekly administration regimen of docetaxel combined with CPT-11 in patients with inoperable or recurrent gastric cancer

Original article

The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study

Original article

Evaluation of malignancy using Ki-67 labeling index for gastric stromal tumor

Editorial

Neoadjuvant chemotherapy: a standard treatment for locally advanced gastric cancer in the near future?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits